Next Article in Journal
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma
Previous Article in Journal
Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer
Previous Article in Special Issue
Advances in Molecular Pathophysiology and Targeted Therapy for Cushing’s Disease
 
 
Editorial

Article Versions Notes

Cancers 2023, 15(23), 5526; https://doi.org/10.3390/cancers15235526
Action Date Notes Link
article xml file uploaded 22 November 2023 11:01 CET Original file -
article xml uploaded. 22 November 2023 11:01 CET Update https://www.mdpi.com/2072-6694/15/23/5526/xml
article pdf uploaded. 22 November 2023 11:01 CET Version of Record https://www.mdpi.com/2072-6694/15/23/5526/pdf
article html file updated 22 November 2023 11:02 CET Original file https://www.mdpi.com/2072-6694/15/23/5526/html
Back to TopTop